The greatest rate of treatment persistence in patients with psoriasis following MACE was seen in those receiving biologics vs other treatment types.

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating other autoimmune diseases. But the use of biologics was complicated by the ...

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

The only recommendation for management of this disease is prescription creams. However, a new study has discovered that switching to a Mediterranean diet could provide significant relief, according to ...

Researchers reviewed hormone variation, life cycles, and their effect on quality of life specific to women with psoriasis.

Johnson & Johnson (NYSE: JNJ) today announced findings from the U.S. dataset from the global ENCOMPASS study evaluating patient and healthcare provider (HCP) perspectives on barriers and unmet needs ...

Approximately 5 million persons in the United States have psoriasis.1 Most have mild disease covering less than 3% of body-surface area, but approximately one fifth have more extensive involvement ...

Whether misidentified as a skin problem or hygiene one, psoriasis is an intricate autoimmune condition that deserves more ...

The global psoriasis treatment market is projected to expand at a compound annual growth rate (CAGR) of 8.5% by 2026. Key factors fueling this growth include the rising prevalence of psoriasis, ...

On World Psoriasis Day 2025, know how stress may spark flare-ups of Psoriasis, why the link matters, and what you can do to ...

By Jonathan Stempel (Reuters) -Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene ...